Market Tracker

09/20 6:41am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

1.74
Delayed Data
As of Sep 19
 +0.06 / +3.57%
Today’s Change
0.49
Today|||52-Week Range
3.68
+77.59%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close1.68
Today’s open1.69
Day’s range1.64 - 1.83
Volume267,516
Average volume (3 months)155,456
Market cap$58.9M
Dividend yield--
Data as of 09/19/2017

Growth & Valuation

Earnings growth (last year)+13.64%
Earnings growth (this year)+26.32%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book18.11

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.20-6.45%
TRILTrillium Therapeutic...+0.05+0.97%
VRMLVermillion Inc-0.01-0.75%
IDXGInterpace Diagnostic...-0.01-0.63%
Data as of 09/19/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$21.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts